UCSF home page About UCSF UCSF Medical Center
UCSF home page | About UCSF | UCSF Medical Center

Skip to TransPortal content

Decrease the text sizeRestore original text sizeIncrease the text size Enlarge Text
Click to increase the text size. Restore Text
Click to restore original text size. Reduce Text
Click to decrease the text size.
Transporter Database banner  
Decrease the text size | Restore text size | Increase the text size
 Text Sizer image
Home About and More Information Transporter Data Index
Search:  
 

Rifamycin SV

Substrate Information
Inhibitor Information
Clinical Drug-drug Interactions

In Vitro Substrates

No substrate information.


Back to top

In Vitro Inhibitors

* denotes drugs that can potentially be used for in vivo (clinical) studies of the designated transporter
Transporter Synonyms Inhibitor IC50 (μM) Ki (μM) Substrate used Cell System Reference
SLCO1A2 OATP1A2, OATP-A Rifamycin SV 11 Bromsulphthalein OATP1A2-expressing oocytes Vavricka, 2002
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Rifamycin SV 2 Bromsulphthalein OATP1B1-expressing oocytes Vavricka, 2002
SLCO1B3 OATP1B3, OATP8 Rifamycin SV 3 Bromsulphthalein OATP1B3-expressing oocytes Vavricka, 2002
SLCO2B1 OATP2B1, OATP-B Rifamycin SV 3 Bromsulphthalein OATP2B1-expressing oocytes Vavricka, 2002
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Rifamycin SV 0.23 Estradiol-17beta-glucuronide HEK-OATP1B1 Chen, 2005
SLCO2B1 OATP2B1, OATP-B Rifamycin SV 3 2.3 Estrone sulfate Caco-2 Annaert, 2010
SLCO2B1 OATP2B1, OATP-B Rifamycin SV 2.7 Estrone sulfate MDCK II-OATP2B1 Kis, 2010
SLCO1B1 OATP1B1, OATP-C, OATP2, LST-1 Rifamycin SV 0.17 Pitavastatin HEK293-OATP1B1 Hirano, 2006

Back to top

Clinical Drug-Drug Interactions

No drug-drug interaction information.


Back to top

Contact us | Glossary

Blue banner